Hantz Financial Services, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
Hantz Financial Services, Inc.
- $6.19 Billion
- Q2 2025
A detailed history of Hantz Financial Services, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 173 shares of ARWR stock, worth $6,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173
Previous 19
810.53%
Holding current value
$6,390
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
322Shares Held
99.5MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$579 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$573 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$392 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$235 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$193 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $3.91B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...